21May/14

How obese women can avoid heart risk – Times of India


Times of India

How obese women can avoid heart risk
Times of India
During the seven years, 373 of the participants—43 per cent of the total—had progressed from having at most a single risk factor for heart disease (i.e., metabolically benign overweight/obese) to at-risk overweight/obese, meaning they had developed
Physical activity could help overweight women avoid heart diseasesZee News

all 10 news articles »

20May/14

Medicine's Dirty Secret: Fecal Transplants Are the Next Big Thing in Health Care – Pacific Standard

Medicine’s Dirty Secret: Fecal Transplants Are the Next Big Thing in Health Care
Pacific Standard
Had you donated blood or plasma, no one would blink. But this? You can’t tell anyone else about this … As the science has progressed, researchers are now comparing the entire collection of microbial inhabitants of the human gut, our microbiome, to a

20May/14

InterMune Announces Additional Pirfenidone Data in Idiopathic Pulmonary … – MarketWatch


Drug Discovery & Development

InterMune Announces Additional Pirfenidone Data in Idiopathic Pulmonary
MarketWatch
Ltd. Under different trade names, pirfenidone is also approved for the treatment of IPF in China, India, Argentina and Mexico. Pirfenidone is not approved for sale in the United States. About IPF Idiopathic pulmonary fibrosis (IPF) is an irreversible
InterMune Up on Esbriet Data Presentation – Analyst BlogNASDAQ
Phase 3 ASCEND Study of Pirfenidone in Idiopathic Pulmonary Fibrosis Stockhouse

all 98 news articles »